Thymosin Alpha 1 may help your patients combat viral infection…
Also known as Tα1, is a naturally occurring thymic polypeptide of 28 N-terminally acetylated amino acids. Wells Pharmacy Network compounds the synthetically manufactured peptide Thymosin alpha 1 (Tα1) in a sterile solution for subcutaneous injection. Tα1 is a powerful modulator of immunity and inflammation as demonstrated in 70 clinical studies with over 3,000 patients ages 13 months to 101 years and immunocompromised patients. It has been studied for use in prophylactic, influenza (multiple types, including Coronavirus / COVID), chronic hepatitis B and C, malignant melanoma, hepatocellular carcinoma and DiGeorge’s syndrome with an immune defect.
Thymosin alpha 1 exhibits a pleiotropic mechanism of therapeutic action, upregulating the innate immune response when required, and downregulating it when not needed. Tα1 acts as a multitask protein restoring immune system homeostasis and cell-mediated immune function in various pathological and physiological conditions, including viral infections.
Thymosin alpha 1 has increases major histocompatibility complex (MHC) class-1 and Toll-like receptor expression, downregulates terminal deoxynucleotide transferase (TdT) activity in TdT1 thymocytes, antagonizes activation-induced (anti-CD3) and glucocorticoid-induced thymocyte apoptosis, stimulates Indoleamine-2,3-Dioxygenase (IDO) activity, increases FoxP3 IL-10 producing regulatory T cells, plays a role in feedback inhibition of cytokine production and dampens immune response to prevent a pro-inflammatory cytokine storm.
If you want more information about purchasing Thymosin alpha 1 from Wells Pharmacy network click the link https://ta1.wellsrx.com/